Literature DB >> 27623968

Glycated albumin: from biochemistry and laboratory medicine to clinical practice.

Elena Dozio1, Nicola Di Gaetano2, Peter Findeisen3, Massimiliano Marco Corsi Romanelli4,5.   

Abstract

This review summarizes current knowledge about glycated albumin. We review the changes induced by glycation on the properties of albumin, the pathological implications of high glycated albumin levels, glycated albumin quantification methods, and the use of glycated albumin as a complementary biomarker for diabetes mellitus diagnosis and monitoring and for dealing with long-term complications. The advantages and limits of this biomarker in different clinical settings are also discussed.

Entities:  

Keywords:  Albumin; Cardiovascular risk; Diabetes mellitus; Diabetes mellitus-related complications; Glycated albumin; Glycation

Mesh：

Substances：

Year:  2016        PMID： 27623968     DOI： 10.1007/s12020-016-1091-6

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


  98 in total

1.  Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.

Authors:  Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Shinsuke Yamada; Yasuo Imanishi; Tsutomu Tabata; Mikio Okamura; Shigeki Okada; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

2.  Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  N Furusyo; T Koga; M Ai; S Otokozawa; T Kohzuma; H Ikezaki; E J Schaefer; J Hayashi
Journal:  Diabetologia       Date:  2011-09-27       Impact factor: 10.122

3.  Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.

Authors:  P J Thornalley; A Langborg; H S Minhas
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

4.  Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy.

Authors:  J R Simard; P A Zunszain; C-E Ha; J S Yang; N V Bhagavan; I Petitpas; S Curry; J A Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

5.  Identification and relative quantification of specific glycation sites in human serum albumin.

Authors:  Andrej Frolov; Ralf Hoffmann
Journal:  Anal Bioanal Chem       Date:  2010-05-22       Impact factor: 4.142

6.  Glycation alters ligand binding, enzymatic, and pharmacological properties of human albumin.

Authors:  Jennifer Baraka-Vidot; Cynthia Planesse; Olivier Meilhac; Valeria Militello; Jean van den Elsen; Emmanuel Bourdon; Philippe Rondeau
Journal:  Biochemistry       Date:  2015-05-06       Impact factor: 3.162

Review 7.  Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications.

Authors:  Jasper W L Hartog; Adriaan A Voors; Stephan J L Bakker; Andries J Smit; Dirk J van Veldhuisen
Journal:  Eur J Heart Fail       Date:  2007-12       Impact factor: 15.534

8.  Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients.

Authors:  Erkan Coban; Mustafa Ozdogan; Aysen Timuragaoglu
Journal:  Acta Haematol       Date:  2004       Impact factor: 2.195

9.  Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.

Authors:  Kazutomi Yoshiuchi; Munehide Matsuhisa; Naoto Katakami; Yoshihisa Nakatani; Kenya Sakamoto; Takaaki Matsuoka; Yutaka Umayahara; Keisuke Kosugi; Hideaki Kaneto; Yoshimitsu Yamasaki; Masatsugu Hori
Journal:  Endocr J       Date:  2008-04-30       Impact factor: 2.349

10.  Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study.

Authors:  David M Nathan; Paula McGee; Michael W Steffes; John M Lachin
Journal:  Diabetes       Date:  2013-08-29       Impact factor: 9.461
View more
  13 in total

1.  Ex vivo instability of glycated albumin: A role for autoxidative glycation.

Authors:  Joshua W Jeffs; Shadi Ferdosi; Hussein N Yassine; Chad R Borges
Journal:  Arch Biochem Biophys       Date:  2017-07-13       Impact factor: 4.013

2.  Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury.

Authors:  Michal Pyzik; Timo Rath; Timothy T Kuo; Sanda Win; Kristi Baker; Jonathan J Hubbard; Rosa Grenha; Amit Gandhi; Thomas D Krämer; Adam R Mezo; Zachary S Taylor; Kevin McDonnell; Vicki Nienaber; Jan Terje Andersen; Atsushi Mizoguchi; Laurence Blumberg; Shalaka Purohit; Susan D Jones; Greg Christianson; Wayne I Lencer; Inger Sandlie; Neil Kaplowitz; Derry C Roopenian; Richard S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-22       Impact factor: 11.205

Review 3.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

4.  Factors associated with glycated albumin in adults without diabetes.

Authors:  Priscila Aparecida Corrêa Freitas; Mayana Kieling Hernandez; Joíza Lins Camargo
Journal:  Med Pharm Rep       Date:  2021-04-29

Review 5.  Urine Proteomics in the Era of Mass Spectrometry.

Authors:  Ashley Beasley-Green
Journal:  Int Neurourol J       Date:  2016-11-22       Impact factor: 2.835

6.  Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation.

Authors:  Elena Dozio; Valentina Corradi; Elena Vianello; Elisa Scalzotto; Massimo de Cal; Massimiliano Marco Corsi Romanelli; Claudio Ronco
Journal:  Mediators Inflamm       Date:  2017-09-25       Impact factor: 4.711

7.  Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression.

Authors:  Danilo C Pinto-Junior; Karolline S Silva; Maria L Michalani; Caio Y Yonamine; João V Esteves; Nelly T Fabre; Karina Thieme; Sérgio Catanozi; Maristela M Okamoto; Patricia M Seraphim; Maria L Corrêa-Giannella; Marisa Passarelli; Ubiratan F Machado
Journal:  Sci Rep       Date:  2018-05-25       Impact factor: 4.379

8.  Postload Glycated Albumin as an Alternate Measure for Diabetes Screening in a Chinese Population.

Authors:  Hang Su; Junling Tang; Xiaojing Ma; Xingxing He; Lingwen Ying; Yufei Wang; Yuqian Bao; Jian Zhou
Journal:  J Diabetes Res       Date:  2018-05-22       Impact factor: 4.011

9.  Potential Markers of Dietary Glycemic Exposures for Sustained Dietary Interventions in Populations without Diabetes.

Authors:  Edith Feskens; Lorraine Brennan; Pierre Dussort; Matthieu Flourakis; Lena M E Lindner; David Mela; Naila Rabbani; Wolfgang Rathmann; Frédérique Respondek; Coen Stehouwer; Stephan Theis; Paul Thornalley; Sophie Vinoy
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

10.  Drug-Induced Falsely Low A1C: Report of a Case Series From a Diabetes Clinic.

Authors:  Kirsten Mitchell; Babu Mukhopadhyay
Journal:  Clin Diabetes       Date:  2018-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.